MCIMX | VMVAX | MCIMX / VMVAX | |
Total Expense Ratio | 1.75 | 0.07 | 2,500% |
Annual Report Gross Expense Ratio | 15.97 | 0.07 | 22,814% |
Fund Existence | 6 years | 14 years | - |
Gain YTD | -3.820 | -2.399 | 159% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 295M | 29.1B | 1% |
Annual Yield % from dividends | 0.74 | 2.40 | 31% |
Returns for 1 year | -14.28 | 3.70 | -386% |
Returns for 3 years | -4.61 | 14.12 | -33% |
Returns for 5 years | 49.27 | 75.12 | 66% |
Returns for 10 years | N/A | 73.65 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNPSX | 20.71 | 0.35 | +1.72% |
Janus Henderson Small Cap Value D | |||
SEPIX | 12.12 | N/A | N/A |
Saratoga Energy & Basic Materials I | |||
GILLX | 21.31 | N/A | N/A |
Goldman Sachs Enhanced U.S. Equity Inst | |||
ESPRX | 36.23 | N/A | N/A |
Allspring Special Small Cap Value R6 | |||
RLEOX | 10.93 | -0.02 | -0.18% |
Lazard Emerging Markets Core Equity R6 |